SCHEMBL7101601

SCHEMBL7101601

NC(=O)C12C(=O)CO[C@H]1CCCN2C(=O)[CH]Cc1ccc(O)cc1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4448316 1.00 DPP4 (0.31) DPP4
SCHEMBL4448472 0.94
SCHEMBL7102347 0.94
SCHEMBL4449150 0.91 HCRTR1 (0.32) DPP4
SCHEMBL7101164 0.91 HCRTR1 (0.32) DPP4
SCHEMBL5092214 0.85
SCHEMBL6803954 0.85 CHRM2 (0.30)
SCHEMBL6803078 0.84 GAA (0.34) DPP4
SCHEMBL6803730 0.84 NPC1 (0.33) DPP4
SCHEMBL7100766 0.84 F2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362052-A1 INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057270-A1 INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed